CClinicalTrials.gg
Status unknownNCT04306666WalantBAXUpdated Mar 13, 2020

Early Rehabilitation After Hand or Wrist Ambulatory Surgery : How to Preserve Locomotion at Home Without Rebound Pain?

An observational study in Hand Surgery and Wrist Surgery, sponsored by University Hospital, Montpellier. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-03-13.

Sponsored by University Hospital, Montpellier · Observational

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this retrospective study is to compare the analgesic efficacy of Walant " Wide Awake Local Anesthesia No Tourniquet " with lidocaine and bupivacaine versus axillary brachial plexus block using mepivacaïne, both performed by anesthesiologists, after hand or wrist ambulatory surgery.

The main objective is to prove that Walant block improve pain relief at home measuring time to first analgesic request.

The secondary objectives are to compare maximal pain, consumption of supplementary analgesics, and the duratin of sensory block between groups.

Read the detailed description

data will be collected on patient records and will be compared between groups of regional anesthesia.

Data will be :

  • time to first analgesic request
  • sensory block
  • rescue analgesia during the first 24 hours after surgery
  • maximal pain score during the first 24 hours after surgery
  • patient satisfaction of managing care
02

Conditions studied

  • Hand Surgery
  • Wrist Surgery

Keywords

  • Regional anesthesia
  • Walant block
03

In context

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All adults patients scheduled for hand or wrist ambulatory surgery

Inclusion criteria

  • All adults patients scheduled for hand or wrist ambulatory surgery since 2016

Exclusion criteria

Exclusion criteria:

  • NA
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Walant group

    Walant group

    Other: Regional anesthesia

  • Axillary Brachial Plexus Block

    Axillary Brachial Plexus Block

    Other: Regional anesthesia

Interventions

  • OtherRegional anesthesia

    Injection of local anesthetics by a regional anesthesia named Walant block (Wide Awak Local anesthesia No Tourniquet)or by axillary brachial plexus block.

06

What researchers measure

Primary outcomes

  1. duration of analgesia

    time to first rescue analgesic request (opioid)

    Time frame: 24 hours

Secondary outcomes

  1. maximal pain score during the first 24 hours after surgery

    Pain assessments during first 24 hours : maximal pain score during the first 24 hours after surgery

    Time frame: 24 hours

  2. total rescue analgesia amounts the first 24 hours after surgery

    Pain assessments during first 24 hours : total rescue analgesia amounts the first 24 hours after surgery

    Time frame: 24 hours

  3. duration of sensory block

    Pain assessments during first 24 hours : duration of sensory block

    Time frame: 24 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — NC

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04306666
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Mar 13, 2020
Start date
Dec 30, 2019
Primary completion
Dec 1, 2020 (estimated)
Completion
Dec 31, 2020 (estimated)
Last update
Mar 13, 2020

Study contacts

olivier CHOQUET, PhD
Contact
o-choquet@chu-montpellier.fr
467338256 ext. 33
olivier CHOQUET, PhD
study director · University Hospital, Montpellier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion